Form D · Biotechnology

ALDER BIOPHARMACEUTICALS INC

Bothell, WA · CIK 0001423824

Offering snapshot reported Jan 26, 2018 · SEC filing

Reported sold
$100M
Offering amount: $260M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 12, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 26, 2018Initial$99,999,952No comparison6SEC filing
Jan 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-304199
The Total Offering Amount includes the value of a warrant that the Issuer is committed to issue.

Source: Form D, filed Jan 26, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Larry Benedict Executive
James Bucher Executive
Paul Carter Director
Paul Cleveland Director
Stephen Dow Director
Randal Hassler Executive
John Latham Executive
Mark James Litton Executive
Alan Bruce Montgomery Director
Deepika Pakianathan Director
Heather Preston Director
Elisabeth Sandoval Executive
Randall Schatzman Director, Executive
Clay Siegall Director
Jeffrey Smith Executive
Wendy Yarno Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11804 North Creek Parkway South
Bothell, WA, 98011